Skip to main content

Table 3 Primary and secondary outcomes: hemoglobin, serum ferritin, TSAT and ESA requirement at 6 month

From: Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial

Parameter HIP IV sucrose p-value
Hgb (g/L) 117 (110–128.8) 113 (107.5-120.3) 0.37
Serum ferritin (ug/L) 85.5 (44–104) 244 (71.5-298) 0.004
TSAT (%) 21.5 (17–29) 21.5 (17–27) 0.82
Average ESA dose at 6 month (ug/month) 60 (7 patients) 50 (5 patients) 0.56